NCT05009199View on ClinicalTrials.gov

Occupancy of Adenosine A2A Receptors Using the PET Radiotracer [18F]MNI-444

PHASE1CompletedINTERVENTIONAL

Enrollment

3

Participants

Timeline

Start Date

June 24, 2021

Primary Completion Date

May 12, 2022

Study Completion Date

May 12, 2022

Conditions

Healthy Volunteer

Interventions

DRUG

[18F]MNI-444

Subjects will undergo PET imaging using \[18F\]MNI-444.

Trial Locations (1)

06510

Invicro, New Haven

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Invicro

OTHER

NCT05009199 - Occupancy of Adenosine A2A Receptors Using the PET Radiotracer [18F]MNI-444 | Biotech Hunter | Biotech Hunter